Coagulation parameter-based nomogram for the diagnosis of obstetric antiphospholipid syndrome and its subtypes

Le résumé fourni par la source

Abstract Currently available classification criteria for obstetric antiphospholipid syndrome (OAPS) are often overly strict and may miss a considerable number of patients with so-called “non-criteria-defined OAPS”. We aimed to establish a diagnostic nomogram based on clinical and laboratory parameters to facilitate the diagnostic efficacy for OAPS by incorporating both criteria – and non-criteria – defined OAPS. We retrospectively analyzed the clinical and laboratory data of 45 patients with criteria-defined OAPS, 57 with non-criteria-defined OAPS, and 80 age-matched healthy controls between September 2023 and March 2024. We established a nomogram for OAPS based on the risk factors identified through logistic regression and evaluated its performance using the receiver-operating characteristic curve, calibration curve, and decision curve analysis. Antinuclear antibody titer, as well as levels of complement C3, anti-β2 glycoprotein I, thrombin-antithrombin complex, and Von Willebrand factor were independent risk factors for OAPS ( P < 0.05). In the training set, the nomogram established using these variables exhibited an area under the curve of 0.97, a sensitivity of 89 %, and a specificity of 94 %. In the validation set, these values were 0.99, 100 % and 88 %, respectively. The nomogram demonstrated enhanced diagnostic capabilities and facilitated more precise treatment guidance for OAPS.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.